Related Experiment Video
Updated: Jul 19, 2026

Quantification of Atherosclerosis in Mice
Published on: June 12, 2019
Macrophage low-density lipoprotein receptor-related protein deficiency enhances atherosclerosis in ApoE/LDLR double
1Vascular Medicine Unit, Department of General Internal Medicine, Leiden University Medical Center, 2300 RC Leiden, The Netherlands.
Objective:
In vitro studies implicate that the low-density lipoprotein receptor (LDLR)-related protein (LRP) in macrophages has a pro-atherogenic potential. In the present study, we investigated the in vivo role of macrophage specific LRP in atherogenesis independent of its role in the uptake of lipoproteins.
Methods And Results:
We generated macrophage-specific LRP-deficient mice on an apoE/LDLR double-deficient background. Macrophage LRP deletion did not affect plasma cholesterol and triglyceride levels, lipoprotein distribution, and blood monocyte counts. Nevertheless, macrophage LRP deficiency resulted in a 1.8-fold increase in total atherosclerotic lesion area in the aortic root of 18-week-old mice. Moreover, LRP deficiency also resulted in a relatively higher number of advanced lesions. Whereas macrophage and smooth muscle cell content did not differ between LRP-deficient mice and control littermates, a 1.7-fold increase in collagen content and 2.3-fold decrease in relative number of CD3+ T cells were observed in lesions from macrophage specific LRP-deficient mice.
Conclusions:
Our data demonstrate that independent of its role in lipoprotein uptake, absence of LRP in macrophages resulted in more advanced atherosclerosis and in lesions that contained more collagen and less CD3+ T cells. In contrast to previous in vitro studies, we conclude that macrophage LRP has an atheroprotective potential and may modulate the extracellular matrix in the atherosclerotic lesions.
Insights
Macrophage low-density lipoprotein receptor (LDLR)-related protein (LRP) deficiency worsens atherosclerosis in vivo. Absence of LRP in macrophages promotes advanced lesions with more collagen and fewer T cells, suggesting an atheroprotective role.
Area of Science:
- Cardiovascular biology
- Atherosclerosis research
- Macrophage biology
Background:
- In vitro studies suggest macrophage LDLR-related protein (LRP) is pro-atherogenic.
- The in vivo role of macrophage LRP in atherogenesis, independent of lipoprotein uptake, remains unclear.
Purpose of the Study:
- To investigate the in vivo role of macrophage-specific LRP in atherogenesis.
- To determine if macrophage LRP influences lesion development independent of lipoprotein metabolism.
Main Methods:
- Generated macrophage-specific LRP-deficient mice on an apoE/LDLR double-deficient background.
- Analyzed atherosclerotic lesion area, composition (macrophages, smooth muscle cells, collagen), and immune cell infiltration (T cells) in aortic roots.
Main Results:
- Macrophage LRP deficiency did not alter plasma lipid levels or lipoprotein distribution.
- Lesions in LRP-deficient mice showed a 1.8-fold increase in total area and a higher proportion of advanced lesions.
- Lesions exhibited increased collagen content (1.7-fold) and decreased CD3+ T cells (2.3-fold reduction).
Conclusions:
- Macrophage LRP plays an atheroprotective role in vivo, independent of lipoprotein uptake.
- Absence of macrophage LRP promotes more advanced atherosclerosis with altered extracellular matrix composition.
- Macrophage LRP may modulate the atherosclerotic microenvironment, influencing collagen deposition and T cell infiltration.
More Related Videos
Related Concept Videos
Inflammation
Atherosclerosis I: Introduction
Atherosclerosis III: Management
Coronary Artery Disease II: Pathophysiology

